Invesaro

Stocks SLB Financial statements

Financial statements

SLB LIMITED/NV financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SLB LIMITED/NV files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue27,81030,44032,81532,91723,60122,92928,09133,13536,28935,708
Cost of revenue7,0578,337
Gross profit20,75322,103
Research and development1,012787702717580554634711749709
General and administrative403432444474365339376364385340
Operating income3,2733,9214,1873,9782,4013,3655,0116,523
Interest expense570566575609563539490503512558
Interest income1101286041333399100174136
Pre-tax income-1,905-1,1832,624-10,418-11,2982,3744,2715,2825,6724,291
Income tax-278330447-311-8124467791,0071,093840
Income from continuing operations-1,687
Net income to minority interests60-839303247517211877
Net income-1,687-1,5052,138-10,137-10,5181,8813,4414,2034,4613,374
EBITDA7,3677,7587,7437,5674,9675,4857,1588,835
EPS, basic-1.24-1.081.54-7.32-7.571.342.432.953.142.38
EPS, diluted-1.24-1.081.53-7.32-7.571.322.392.913.112.35
Shares, basic (weighted)1,3571,3881,3851,3851,3901,4001,4161,4251,4211,421
Shares, diluted (weighted)1,3571,3881,3931,3851,3901,4271,4371,4431,4361,437

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents2,9291,7991,4331,1378441,7571,6552,9003,5443,036
Short-term investments6,3283,2901,3441,0302,1621,3821,2391,0891,1251,176
Receivables9,3878,0847,8817,7475,2475,3156,7667,8128,0118,689
Inventory4,2254,0464,0104,1303,3543,2723,9994,3874,3755,032
Other current assets1,0581,2781,0631,4861,3129281,3441,5301,5151,580
Total current assets23,92718,49715,73115,53012,91912,65415,00317,71818,57019,513
Property, plant and equipment12,82111,57611,6799,2706,8266,6076,6077,2407,3597,894
Lease right-of-use assets1,8001,300710553
Goodwill24,99025,11824,93116,04212,98012,99012,98214,08414,59316,794
Intangible assets9,8559,3548,7277,0893,4553,2112,9923,2393,0124,988
Other non-current assets3,8095,1967,3006,2484,1934,1833,9704,0523,7663,896
Total assets77,95671,98770,50756,31242,43441,51143,13547,95748,93554,868
Accounts payable4,0044,6144,7094,7902,9373,2053,9214,6134,2304,859
Accrued liabilities1,3491,2961,2441,4451,5241,3771,4931,6251,4751,586
Deferred revenue1,088752
Short-term debt1,975
Total current liabilities15,05915,28213,48613,09810,49110,35912,01813,39512,81114,721
Long-term debt16,46314,87514,64414,77016,03613,28610,59410,84211,0239,742
Other non-current liabilities1,5301,8373,1972,8102,3502,2552,3082,0462,1721,991
Total liabilities36,42734,72633,92132,13629,94526,22525,14626,59826,58527,577
Total debt18,43814,87514,64414,77016,03613,28610,59410,84211,0239,742
Retained earnings36,47032,19031,65818,7517,0188,19910,71913,49716,39518,067
Treasury stock-3,550-4,049-4,006-3,631-3,033-2,233-1,016-678-1,773-3,576
Other comprehensive income-4,643-4,274-4,622-4,438-4,884-3,570-3,855-4,254-4,950-4,736
Shareholders' equity41,07836,84236,16223,76012,07115,00417,68520,18921,13026,109
Minority interests4514194244164182823041,1701,2201,182
Total equity41,52937,26136,58624,17612,48915,28617,98921,35922,35027,291
Total liabilities and equity77,95671,98770,50756,31242,43441,51143,13547,95748,93554,868
Shares outstanding1,3911,3841,3831,3851,3921,4031,4201,4271,4011,495

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-1,627-1,5132,177-10,107-10,4861,9283,4924,2754,5793,451
Depreciation and amortization4,0943,8373,5563,5892,5662,1202,1472,3122,5192,643
Stock-based compensation267343345405397324313293316332
Deferred income tax-379-260-245-1,011-1,248-31-3928-41-279
Change in receivables1,098-1244301422,345-36-1,728-659-236-75
Change in inventory800108-10-3148675-737-254-101-72
Change in payables-1,680-737-824-161-3,330160704780-635218
Cash from operations6,2615,6635,7135,4312,9444,6513,7206,6376,6026,489
Capital expenditures-2,055-2,107-2,160-1,724-1,116-1,141-1,618-1,939-1,931-1,694
Purchases of investments-1,031-1,609-981-781-303-474-587-507-483-428
Sales and maturities of investments3,2771,943317
Cash from investing-624-1,779-1,040-2,011-2,353-919-1,388-2,783-3,145-1,412
Debt issued3,6402,3718984,0045,837349941,475
Debt repaid-5,630-2,961-2,861-4,799-4,975-2,076-1,650-1,578-955-1,597
Stock issued1848534238190297
Share buybacks-778-969-400-278-26-694-1,737-2,414
Dividends paid-2,647-2,778-2,770-2,769-1,734-699-848-1,317-1,533-1,602
Cash from financing-5,428-5,033-5,020-3,718-873-2,824-2,382-2,512-2,772-5,642
Net change in cash-1,149-347-298-282908-501,342685-565
Free cash flow4,2063,5563,5533,7071,8283,5102,1024,6984,6714,795
Interest paid599572592558598560562503510560
Income taxes paid750-446287395825917161,0601,1401,198

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $51.54 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Pre-tax margin10.8%Pre-tax income / revenue.
Net margin8.5%Net income / revenue.
FCF margin13.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin18.0%Cash from operations / revenue.
Effective tax rate19.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)11.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.6%Net income / average total assets.
R&D / revenue1.9%Research and development expense / revenue.
Stock-based pay / revenue0.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.7%Capital expenditures / revenue.
D&A / revenue7.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y8.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-24.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-0.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y-24.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-0.6%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-1.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y20.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y17.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y2.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y31.6%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y21.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y23.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y16.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y12.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.44xCurrent assets / current liabilities.
Quick ratio0.94x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.29x(Cash + short-term investments) / current liabilities.
Debt / equity0.43xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.1%Total debt / total assets.
Liabilities / assets50.9%Total liabilities / total assets.
Net debt$7.07BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$6.18BCurrent assets - current liabilities.
Goodwill and intangibles / assets39.4%(Goodwill + intangible assets) / total assets.
Tangible book value$4.20BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.65xRevenue / average total assets.
Fixed asset turnover4.70xRevenue / average property, plant and equipment.
Receivables turnover3.98xRevenue / average receivables.
Days sales outstanding92 days365 x average receivables / revenue.
FCF conversion155.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow26.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.06Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$24.15Revenue / diluted weighted shares.
FCF per share$3.19Free cash flow / diluted weighted shares.
Operating cash flow per share$4.34Cash from operations / diluted weighted shares.
Book value per share$17.57Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$2.83Tangible book value / shares outstanding.
Cash per share$2.74(Cash + short-term investments) / shares outstanding.
Payout ratio54.7%Dividends paid / net income, when net income is positive.
Dividends / FCF35.3%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF25.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$76.49BShare price x shares outstanding.
Enterprise value$83.56BMarket cap + total debt - cash - short-term investments.
P/E24.7xMarket cap / net income. Only when net income is positive.
P/S2.10xMarket cap / revenue.
P/B2.93xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book18.2xMarket cap / tangible book value, when positive.
P/FCF15.9xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF11.7xMarket cap / cash from operations, when positive.
EV/Sales2.30xEnterprise value / revenue.
EV/FCF17.4xEnterprise value / free cash flow, when both are positive.
FCF yield6.3%Free cash flow / market cap.
Earnings yield4.1%Net income / market cap (the inverse of P/E).
Dividend yield2.2%Dividends paid over the period / market cap.
Shareholder yield3.8%(Dividends paid + share buybacks) / market cap.
What was SLB LIMITED/NV's revenue in fiscal 2025?

SLB LIMITED/NV reported revenue of $35.71B for fiscal 2025, 1.6% lower than the year before.

Was SLB LIMITED/NV profitable in fiscal 2025?

Yes. Net income was $3.37B, a net margin of 9.4%.

How much free cash flow did SLB LIMITED/NV generate in fiscal 2025?

Cash from operations of $6.49B minus capital expenditures of $1.69B left free cash flow of $4.80B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SLB LIMITED/NV